BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 10, 2012
View Archived Issues
Scientists at Actelion Pharmaceuticals patent new FPR2/ALX receptor agonists
Read More
New MPGES-1 inhibitors designed in Germany
Read More
New long-acting drug is well tolerated as once-weekly growth hormone replacement therapy
Read More
PARP-1/2 inhibitor shows promising safety profile in patients with cancer
Read More
Lupin presents novel GLP-1 receptor modulators
Read More
New agents for cancer reported by Kasina Laila Innova Pharmaceuticals
Read More
First-in-human study of EP-100 complete
Read More
Ampio Pharmaceticals discloses data from Optina trial
Read More
Novel DPP IV inhibitors prepared
Read More
OncoSec launches new phase II OMS ElectroImmunotherapy trial
Read More
DNAzyme is effective in models of skin cancer
Read More
FDA grants priority review for Xarelto applications
Read More
Proteostasis Therapeutics discloses novel prosteostasis regulators
Read More
ACT clear to proceed with dry AMD trial
Read More
Repros reaches agreement with FDA on pivotal Androxal studies
Read More
Titan Pharmaceuticals completes study of nonfluctuating dopamine receptor agonist drug
Read More
Lux Biosciences completes enrollment in phase III trial in noninfectious uveitis
Read More
TONIX reports encouraging pharmacokinetic data on TNX-102
Read More
Potential biomarker of AMD identified
Read More
Acusphere gives update on MAA for Imagify
Read More
FDA places clinical hold on IB-1001 trials
Read More
Pergamum reports topline data from phase II trial in prevention of postsurgical adhesions
Read More
Sanofi withdraws MAA for anticoagulant drug
Read More
Phase III Halaven study in new breast cancer indication does not meet primary endpoints
Read More
Xiaflex approved in Canada
Read More
Norwegian government awards grant to Bionor
Read More